Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of tissue mRNA and serum antigen levels of members of the urokinase-type plasminogen activator system with clinical and prognostic parameters in prostate cancer.
Al-Janabi O, Taubert H, Lohse-Fischer A, Fröhner M, Wach S, Stöhr R, Keck B, Burger M, Wieland W, Erdmann K, Wirth MP, Wullich B, Baretton G, Magdolen V, Kotzsch M, Füssel S. Al-Janabi O, et al. Among authors: wieland w. Biomed Res Int. 2014;2014:972587. doi: 10.1155/2014/972587. Epub 2014 Apr 29. Biomed Res Int. 2014. PMID: 24877154 Free PMC article. Clinical Trial.
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.
Wach S, Nolte E, Szczyrba J, Stöhr R, Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, Ekici AB, Grässer F, Wullich B. Wach S, et al. Among authors: wieland w. Int J Cancer. 2012 Feb 1;130(3):611-21. doi: 10.1002/ijc.26064. Epub 2011 May 9. Int J Cancer. 2012. PMID: 21400514 Free article.
Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
Szczyrba J, Nolte E, Wach S, Kremmer E, Stöhr R, Hartmann A, Wieland W, Wullich B, Grässer FA. Szczyrba J, et al. Among authors: wieland w. Mol Cancer Res. 2011 Jun;9(6):791-800. doi: 10.1158/1541-7786.MCR-10-0573. Epub 2011 May 18. Mol Cancer Res. 2011. PMID: 21593139
The microRNA profile of prostate carcinoma obtained by deep sequencing.
Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F. Szczyrba J, et al. Among authors: wieland w. Mol Cancer Res. 2010 Apr;8(4):529-38. doi: 10.1158/1541-7786.MCR-09-0443. Epub 2010 Mar 30. Mol Cancer Res. 2010. PMID: 20353999
The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer.
Hart M, Wach S, Nolte E, Szczyrba J, Menon R, Taubert H, Hartmann A, Stoehr R, Wieland W, Grässer FA, Wullich B. Hart M, et al. Among authors: wieland w. FEBS J. 2013 May;280(9):2105-16. doi: 10.1111/febs.12236. Epub 2013 Apr 8. FEBS J. 2013. PMID: 23480797 Free article.
Risk and timing of biochemical recurrence in pT3aN0/Nx prostate cancer with positive surgical margin - A multicenter study.
Karl A, Buchner A, Tympner C, Kirchner T, Ganswindt U, Belka C, Ganzer R, Wieland W, Eder F, Hofstädter F, Schilling D, Sievert KD, Stenzl A, Scharpf M, Fend F, Vom Dorp F, Rübben H, Schmid KW, Porres-Knoblauch D, Heidenreich A, Hangarter B, Knüchel-Clarke R, Rogenhofer M, Wullich B, Hartmann A, Comploj E, Pycha A, Hanspeter E, Pehrke D, Sauter G, Graefen M, Gratzke C, Stief C, Wiegel T, Haese A. Karl A, et al. Among authors: wieland w. Radiother Oncol. 2015 Jul;116(1):119-24. doi: 10.1016/j.radonc.2015.06.021. Epub 2015 Jun 29. Radiother Oncol. 2015. PMID: 26138059
229 results